Vascular News and Research

RSS

Genentech's Lucentis Phase III trials in DME meets primary endpoints

Genentech, a member of the Roche Group, announced today that the second of two Phase III trials evaluating Lucentis in patients with diabetic macular edema met its primary endpoint.

28 Mar 2011

FDA approves humanitarian device exemption for Elana Surgical Kit in cerebral bypass

Dutch medical device manufacturer, Elana bv, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a humanitarian device exemption (HDE), enabling a lifesaving cerebral bypass. Elana bv is a corporate spin-off from the University Medical Centre Utrecht, the Netherlands.

25 Mar 2011

Teleflex to distribute Perouse line of POLYSITE intravenous implantable infusion ports

Teleflex Incorporated, a global provider of medical technology products, announced a global distribution agreement with Perouse Medical under which Teleflex will distribute the Perouse line of POLYSITE® intravenous implantable infusion ports.

25 Mar 2011

Contention continues a year later

News outlets remark on the continuing ferocity of the health overhaul debate — even a year later — as its advocates and detractors continue efforts to advance or block the measure's implementation.

25 Mar 2011

AHA to honor BIDMC investigator for groundbreaking Vascular Biology research

Alterations in blood vessel dilation lie at the heart of coronary artery health: When vessels dilate, blood and oxygen supplies successfully reach the heart. When vessels contract, blood and oxygen are diminished, leading to coronary artery disease.

23 Mar 2011

FDA approves Harvest's BMAC System IDE trial to treat non-reconstructable Critical Limb Ischemia

Harvest Technologies Corp. announced today that the FDA has approved the company sponsored 210-patient IDE clinical trial to be conducted at twenty-five sites in the U.S. using the company's proprietary Bone Marrow Aspiration Concentrate (BMAC) System to treat patients with non-reconstructable Critical Limb Ischemia (CLI).

23 Mar 2011

Heart attack risk during sex is low: Study

According to the latest research from Tufts Medical Center, sexual intercourse, previously believed does increase the risk of a heart attack, but the risk is still small and only rises during and soon after the deed.

22 Mar 2011

Patients with bone cancer can benefit from radical surgery

During a radical surgery to treat a rare bone cancer, surgeons at UC San Diego Health System and Moores Cancer Center removed 50 percent of a patient's pelvis. Instead of amputating the connected leg, the surgical team, comprised of orthopaedic, vascular and urologic experts, saved the entire limb. The patient was able to walk with assistance five weeks after surgery.

22 Mar 2011

Cordis launches new PTA Balloon Catheter to treat PAD

Cordis Corporation is pleased to announce the launch of SLEEK® OTW Catheter, a new .014" Percutaneous Transluminal Angioplasty Balloon Catheter designed to help physicians save limbs and enhance patients' lives.

22 Mar 2011

First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.

21 Mar 2011

Physical ill-health reduces life expectancy of people with severe mental illness

Physical ill-health is rife among the severely mentally ill in Britain, according to new research published today by the University of East Anglia (UEA).

21 Mar 2011

FDA Neurological Devices Advisory Panel voted to recommend approval for Pipeline Embolization Device

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration Neurological Devices Advisory Panel voted to recommend approval for Pipeline Embolization Device, intended for the endovascular treatment of large or giant wide-necked intracranial aneurysms in the cavernous and paraclinoid regions of the internal carotid artery.

19 Mar 2011

Scientists discover enzyme family that plays a crucial role in regulating cell motility

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that members of an enzyme family found in humans and throughout the plant and animal kingdoms play a crucial role in regulating cell motility. Their findings suggest an entirely new strategy for treating conditions ranging from diabetic ulcers to metastatic cancer.

19 Mar 2011

CDC to award $2M grant to continue CARPE program in preventing healthcare-associated infections

The federal Centers for Disease Control and Prevention is awarding researchers at the Cook County Health & Hospitals System and Rush University Medical Center a $2 million grant to continue a successful program aimed at preventing healthcare-associated infections, antibiotic resistance, and other adverse events associated with healthcare.

19 Mar 2011

Cancer Care Partners first in U.S. to use new, advanced cancer treatment

On March 7, 2010, Cancer Care Partners became the first cancer center in the United States to use the new TomotherapyHD, a comprehensive, image guided radiation therapy system that enables Cancer Care Partners to more efficiently treat complex tumors with improved precision.

18 Mar 2011

Corindus begins CorPath Percutaneous Robotic-Enhanced Coronary Intervention Study trial

Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that the clinical trial of its CorPath PRECISE has begun.

16 Mar 2011

DJO Global signs definitive agreement to purchase Rikco for $254.6 million

DJO Global, Inc., a leading provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that one of its indirect subsidiaries has signed a definitive agreement to purchase Rikco International, LLC, D/B/A Dr. Comfort, for approximately $254.6 million in cash.

15 Mar 2011

New study: Two peptide agent combination might block tumor growth

A new study suggests that combining two experimental anticancer peptide agents might simultaneously block formation of new tumor blood vessels while also inhibiting the growth of tumor cells.

15 Mar 2011

KAI initiates enrollment in KAI-4169 Phase 2 study for secondary hyperparathyroidism

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).

14 Mar 2011

Omthera commences dosing in pivotal Epanova Phase III EVOLVE trial in patients with very high triglycerides

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

14 Mar 2011

Vascular News and Research

Genentech's Lucentis Phase III trials in DME meets primary endpoints

FDA approves humanitarian device exemption for Elana Surgical Kit in cerebral bypass

Teleflex to distribute Perouse line of POLYSITE intravenous implantable infusion ports

Contention continues a year later

AHA to honor BIDMC investigator for groundbreaking Vascular Biology research

FDA approves Harvest's BMAC System IDE trial to treat non-reconstructable Critical Limb Ischemia

Heart attack risk during sex is low: Study

Patients with bone cancer can benefit from radical surgery

Cordis launches new PTA Balloon Catheter to treat PAD

First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

Physical ill-health reduces life expectancy of people with severe mental illness

FDA Neurological Devices Advisory Panel voted to recommend approval for Pipeline Embolization Device

Scientists discover enzyme family that plays a crucial role in regulating cell motility

CDC to award $2M grant to continue CARPE program in preventing healthcare-associated infections

Cancer Care Partners first in U.S. to use new, advanced cancer treatment

Corindus begins CorPath Percutaneous Robotic-Enhanced Coronary Intervention Study trial

DJO Global signs definitive agreement to purchase Rikco for $254.6 million

New study: Two peptide agent combination might block tumor growth

KAI initiates enrollment in KAI-4169 Phase 2 study for secondary hyperparathyroidism

Omthera commences dosing in pivotal Epanova Phase III EVOLVE trial in patients with very high triglycerides

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News